Skip to content

About us
Our focus
Team
- Management board
- Advisory board
Investors
Drug pipeline
News
Contact

Menu

About us
Our focus
Team
- Management board
- Advisory board
Investors
Drug pipeline
News
Contact

Management board

Home / Team / Management board

P. Victor Schut
Chief Executive Officer

Dr. Frederik Deroose
Chief Knowledge Officer

About

AGILeBiotics B.V. is a pharmaceutical company focusing on the development of novel antibiotics for the treatment of multi-drug resistant infections

Latest news

AGILeBiotics contributes to fight against future pandemic infections (e.g. COVID-19)

7 April 2020

AGILeBiotics B.V. appoints new CEO Victor Schut

6 April 2020

AGILeBiotics won the Investors Forum 2019 at the Dutch Life Sciences Conference

28 November 2019

AGILeBiotics has been awarded the EUSMI-H2020 grant for up-scale synthesis of pre-clinical antibiotic candidate Toframicin

14 October 2019

Copyright © 2018 AGILeBiotics | All Rights Reserved. | Webdevelopment Skitter